857 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Unknown  Non-Small Cell Lung Cancer and Quality of Life
Condition: Non Small Cell Lung Cancer
Intervention:
22 Not yet recruiting The Effect Of Aspirin On Survival in Lung Cancer
Conditions: Non Small Cell Lung Cancer;   Survival;   Aspirin
Interventions: Drug: Aspirin 75 mg;   Other: no aspirin
23 Unknown  Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: radiotherapy combined with EP;   Drug: radiotherapy / EP combined with recombinant human endostatin
24 Recruiting Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: hypofractionated radiation therapy;   Radiation: intensity-modulated radiation therapy
25 Recruiting Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dacomitinib Plus Blinded Doxycycline or Placebo;   Drug: Dacomitinib Plus Probiotic Plus Topical Alclometasone cream;   Drug: Dacomitinib
26 Recruiting Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers
Conditions: Non Small Cell Lung Cancer;   Adenocarcinoma
Interventions: Drug: Gefitinib;   Drug: Placebo;   Drug: Pemetrexed plusCIsplatin
27 Recruiting Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
Condition: Non-small Cell Lung Cancer
Interventions: Biological: Nivolumab;   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Pemetrexed;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Erlotinib;   Biological: Ipilimumab
28 Recruiting Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Condition: Non Small Cell Lung Cancer
Interventions: Procedure: Stereostatic Radiosurgery;   Drug: Erlotinib
29 Recruiting Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin and gemcitabine combination with Bevacizumab;   Drug: Gemcitabine combined with cisplatin chemotherapy
30 Recruiting PKCi & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer
Conditions: Adenosquamous Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: sirolimus;   Drug: auranofin
31 Recruiting Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
32 Recruiting Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)
Condition: Non-small Cell Lung Cancer Patients
Intervention: Procedure: 18F-FDG-PET scan
33 Unknown  Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Interventions: Drug: chemotherapy;   Drug: Concurrent chemoradiation therapy;   Radiation: Concurrent chemoradiation therapy
34 Recruiting Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Drug: cisplatin, docetaxel
35 Recruiting Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
Conditions: Solid Tumors;   Breast Cancer;   Non-small Cell Lung Cancer;   Prostate Cancer;   Gastric Cancer
Interventions: Drug: Docetaxel;   Drug: Sunitinib
36 Recruiting Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases
Conditions: Carcinoma, Non-Small-Cell Lung;   Neoplasm Metastasis
Interventions: Radiation: 34 Gy in a single fraction;   Radiation: 54Gy 18Gy/fr. x 3 fractions;   Radiation: 50Gy (12 x 5 fr.s);   Radiation: 60Gy (7.5Gy x 8fr.)
37 Recruiting MODEL (Maintenance Versus Observation After inDuction Chemotherapy in Non-progressing Elderly Patients With Advanced Non-small Cell Lung Cancer)
Condition: Non Small Cell Lung Cancer (Squamous or Non Squamous)
Interventions: Drug: Pemetrexed;   Drug: Gemcitabine;   Drug: Induction chemotherapy
38 Not yet recruiting Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS)
Conditions: Weight Loss;   Cachexia
Intervention:
39 Recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung
Condition: Non-small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel/carboplatin
40 Recruiting Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease
Condition: Non-small Cell Lung Cancer
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years